BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 6266655)

  • 1. Relationship between benzo(a)pyrene-induced DNA base modification and frequency of reverse mutations in mutant strains of Salmonella typhimurium.
    Fahl WE; Scarpelli DG; Gill K
    Cancer Res; 1981 Sep; 41(9 Pt 1):3400-6. PubMed ID: 6266655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation at separate gene loci in Salmonella typhimurium TA100 related to DNA nucleotide modification by stereoisomeric benzo(a)pyrene 7,8-diol-9,10-epoxides.
    Burgess JA; Stevens CW; Fahl WE
    Cancer Res; 1985 Sep; 45(9):4257-62. PubMed ID: 3928153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenicity and cytotoxicity of benzo(a)pyrene benzo-ring epoxides.
    Wood AW; Wislocki PG; Chang RL; Levin W; Lu AY; Yagi J; Hernandez O; Herina DM; Conney AH
    Cancer Res; 1976 Sep; 36(9 pt.1):3358-66. PubMed ID: 788899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of 3-hydroxybenzo(a)pyrene on the mutagenicity and tumorigenicity of (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene.
    Huang MT; Wood AW; Chang RL; Yagi H; Sayer JM; Jerina DM; Conney AH
    Cancer Res; 1986 Feb; 46(2):558-66. PubMed ID: 3079665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rat and human explant metabolism, binding studies, and DNA adduct analysis of benzo(a)pyrene and its 6-nitro derivative.
    Garner RC; Stanton CA; Martin CN; Harris CC; Grafstrom RC
    Cancer Res; 1985 Dec; 45(12 Pt 1):6225-31. PubMed ID: 4063973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fjord- and bay-region diol-epoxides investigated for stability, SOS induction in Escherichia coli, and mutagenicity in Salmonella typhimurium and mammalian cells.
    Glatt H; Piée A; Pauly K; Steinbrecher T; Schrode R; Oesch F; Seidel A
    Cancer Res; 1991 Mar; 51(6):1659-67. PubMed ID: 1900215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenicity of the bay-region diol-epoxides and other benzo-ring derivatives of dibenzo(a,h)pyrene and dibenzo(a,i)pyrene.
    Wood AW; Chang RL; Levin W; Ryan DE; Thomas PE; Lehr RE; Kumar S; Sardella DJ; Boger E; Yagi H; Sayer JM; Jerina DM; Conney AH
    Cancer Res; 1981 Jul; 41(7):2589-97. PubMed ID: 7018665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of mutation and comparison of mutation profiles in the hprt gene of Chinese hamster ovary cells treated with benzo[a]pyrene trans-7,8-diol-anti-9,10-epoxide, 1-nitrobenzo[a]pyrene trans-7,8-diol-anti-9,10-epoxide, and 3-nitrobenzo[a]pyrene trans-7,8- diol-anti-9,10-epoxide.
    Zhan DJ; Heflich RH; Fu PP
    Environ Mol Mutagen; 1996; 27(1):19-29. PubMed ID: 8625944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermis: the major site of cutaneous benzo(a)pyrene and benzo(a)pyrene 7,8-diol metabolism in neonatal BALB/c mice.
    Das M; Bickers DR; Mukhtar H
    Drug Metab Dispos; 1986; 14(6):637-42. PubMed ID: 2877819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of benzo(a)pyrene metabolite:DNA adducts in lung and liver of mice.
    Kulkarni MS; Anderson MW
    Cancer Res; 1984 Jan; 44(1):97-101. PubMed ID: 6317174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenic activity of the 4,5- and 9,10-dihydrodiols of benzo[j]fluoranthene and their syn- and anti-dihydrodiol epoxides in Salmonella typhimurium.
    Marshall MV; He ZM; Weyand EH; Rice JE; LaVoie EJ
    Environ Mol Mutagen; 1993; 22(1):34-45. PubMed ID: 8339723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both replication bypass fidelity and repair efficiency influence the yield of mutations per target dose in intact mammalian cells induced by benzo[a]pyrene-diol-epoxide and dibenzo[a,l]pyrene-diol-epoxide.
    Lagerqvist A; Håkansson D; Prochazka G; Lundin C; Dreij K; Segerbäck D; Jernström B; Törnqvist M; Seidel A; Erixon K; Jenssen D
    DNA Repair (Amst); 2008 Aug; 7(8):1202-12. PubMed ID: 18479980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Species-specific enhancement by 7,8-benzoflavone of hepatic microsomal metabolism of benzo[e]pyrene 9,10-dihydrodiol to bay-region diol epoxides.
    Thakker DR; Levin W; Buening M; Yagi H; Lehr RE; Wood AW; Conney AH; Jerina DM
    Cancer Res; 1981 Apr; 41(4):1389-96. PubMed ID: 7194138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumorigenicity studies with diol-epoxides of benzo(a)pyrene which indicate that (+/-)-trans-7beta,8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene is an ultimate carcinogen in newborn mice.
    Kapitulnik J; Wislocki PG; Levin W; Yagi H; Jerina DM; Conney AH
    Cancer Res; 1978 Feb; 38(2):354-8. PubMed ID: 620406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of DNA and globin adducts of polynuclear aromatic hydrocarbon diol epoxides by gas chromatography-mass spectrometry and -3H-CH3I postlabeling of released tetraols.
    Melikian AA; Sun P; Coleman S; Amin S; Hecht SS
    Chem Res Toxicol; 1996 Mar; 9(2):508-16. PubMed ID: 8839056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal hyperplasia after topical application of benzo (a) pyrene, benzo (a) pyrene diol epoxides, and other metabolites.
    Bresnick E; McDonald TF; Yagi H; Jerina DM; Levin W; Wood AW; Conney AH
    Cancer Res; 1977 Apr; 37(4):984-90. PubMed ID: 844052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenicity of the enantiomers of the diastereomeric bay-region benz(a)anthracene 3,4-diol-1,2-epoxides in bacterial and mammalian cells.
    Wood AW; Chang RL; Levin W; Yagi H; Thakker DR; van Bladeren PJ; Jerina DM; Conney AH
    Cancer Res; 1983 Dec; 43(12 Pt 1):5821-5. PubMed ID: 6357432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzo(a)pyrene:DNA adduct formation in early-passage Wistar rat embryo cell cultures: evidence for multiple pathways of activation of benzo(a)pyrene.
    Pruess-Schwartz D; Baird WM
    Cancer Res; 1986 Feb; 46(2):545-52. PubMed ID: 3940629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of benzo(a)pyrene and benzo (a)pyrene derivatives to mutagenic products by highly purified hepatic microsomal enzymes.
    Wood AW; Levin W; Lu AY; Yagi H; Hernandez O; Jerina DM; Conney AH
    J Biol Chem; 1976 Aug; 251(16):4882-90. PubMed ID: 821945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutagenic and cell-transforming activities of triol-epoxides as compared to other chrysene metabolites.
    Glatt H; Seidel A; Bochnitschek W; Marquardt H; Marquardt H; Hodgson RM; Grover PL; Oesch F
    Cancer Res; 1986 Sep; 46(9):4556-65. PubMed ID: 3524815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.